Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2003
09/10/2003EP1341908A2 Targeted enzyme prodrug therapy
09/10/2003EP1341907A2 Target enzymes
09/10/2003EP1341809A2 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test
09/10/2003EP1341807A2 Interferon-alpha induced gene
09/10/2003EP1341792A2 Amido ether substituted imidazoquinolines
09/10/2003EP1341791A2 Thioether substituted imidazoquinolines
09/10/2003EP1341790A2 Sulfonamido ether substituted imidazoquinolines
09/10/2003EP1341789A2 Aryl ether substituted imidazoquinolines
09/10/2003EP1341788A2 Pyrazolopyridines
09/10/2003EP1341787A2 Antimicrobial 2-pyridones, their compositions and uses
09/10/2003EP1341782A2 Inhibitors of p38 kinase
09/10/2003EP1341781A1 Antimicrobial quinolones
09/10/2003EP1341769A2 Bacterial gyrase inhibitors and uses thereof
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341766A1 Imidazolone derivatives for the treatment of viral diseases
09/10/2003EP1341758A2 Coniosetin and derivatives thereof, method for producing the same and use thereof
09/10/2003EP1341754A1 Substituted anthranilic acids
09/10/2003EP1341546A2 Kyberdrug as autovaccines with immune-regulating effects
09/10/2003EP1341544A1 Blocking the adsorption of germs in birds
09/10/2003EP1341540A2 Tyrosine kinase inhibitors
09/10/2003EP1341539A1 Anti-inflammatory agents
09/10/2003EP1341537A2 Pharmaceutically active isoindoline derivatives
09/10/2003EP1341500A1 Antifungal nail composition and method of use
09/10/2003EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
09/10/2003EP1179012B9 Long lasting fusion peptide inhibitors of viral infection
09/10/2003EP1169044B1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
09/10/2003EP1082300B1 3-[(1'-n-methylamino)ethyl-n-benzyl]pyrrolidine monomethanesulfonate
09/10/2003EP1054689B1 Strategically modified hepatitis b core proteins and their derivatives
09/10/2003EP1053029B1 Sterile complex of therapeutic peptide bond to a polysaccharide
09/10/2003EP1037633B1 Antiviral compounds
09/10/2003EP0914091B1 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003EP0906122B1 Activated linkers and methods for making and purifying the same
09/10/2003EP0885237B1 Oligonucleotide analogues
09/10/2003EP0594732B1 Humanized antibody against cd18
09/10/2003CN1441809A Antifungal and/or antibacterial peptides, preparation methods and composition containing same
09/10/2003CN1441807A Hepatitis B core antigen fusion proteins
09/10/2003CN1441806A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties
09/10/2003CN1441805A Antitumoral analogue of Et-743
09/10/2003CN1441804A Tetrahydro-heterocyclozaepinyl pyrimidine derivatives
09/10/2003CN1441803A Indoloquinazolinones
09/10/2003CN1441787A Modulators of TNF-alpha signaling
09/10/2003CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues
09/10/2003CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
09/10/2003CN1441779A Proline derivatives and use thereof as drugs
09/10/2003CN1441778A Pleuromutilin derivatives having antibacterial activity
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors
09/10/2003CN1441770A Modified forms of pharmacologically active agents and uses therefor
09/10/2003CN1441680A Cyclodextrin containing glycopeptide antibiotic pharmaceutical compositions
09/10/2003CN1441676A Method of treatment using ligand-immunogen conjugates
09/10/2003CN1441675A Compositions and methods for achieving immune suppression
09/10/2003CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors
09/10/2003CN1441668A Compositions and methods to improve oral absorption of antimicrobial agents
09/10/2003CN1441667A Pharmaceutical compositions
09/10/2003CN1441664A Synergistic antiplaque/antigivitis oral composition
09/10/2003CN1440978A Pyloric spirobacterium inhibitor
09/10/2003CN1440973A Optical pure analog of camptothecine
09/10/2003CN1440972A Optical pure synthetic intermediate of camptothecine and its preparing method
09/10/2003CN1440816A Improvement for diagnosis and/or therapeutic agnet and its relative improvement
09/10/2003CN1440814A Specific HIV RNA degrading agent and its prepn
09/10/2003CN1440810A Prepn of clostridium welchil toxoid vaccine and antitoxin serum
09/10/2003CN1440808A New use of neutral proteinase in treating hepatitis
09/10/2003CN1440798A Tinea treating medicine
09/10/2003CN1440780A Food granule with the functions of treating hepatosis, pretecting liver and lowering blood pressure
09/10/2003CN1440774A Ointment for treating burns and scalds, sore, bone tuberculosis and wounds
09/10/2003CN1440772A Composite Chinese medicine for treating bloat and its prepn process and quality control method
09/10/2003CN1440754A Medicine recipe and prepn process
09/10/2003CN1440751A Matrix metal proteinase and tumor necrosis inhibitor
09/10/2003CN1440750A Delayed releasing kurarinol prepn
09/10/2003CN1440746A Terbinafine hydrochloride capsule
09/10/2003CN1120719C Aloes lozenge and preparing method thereof
09/09/2003US6617345 Cyclooxygenase-2 inhibitor is (5-bromo-2-(4-fluorophenyl )-3-(4-(methylsulfonyl)phey)-thiophene), N-(2-(cyclohexyloxy 4-nitrophenyl)-methanesulfonamide), meloxicam, flosulide or cyclic substituted phenyl sulfones or sulfonamides
09/09/2003US6617339 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
09/09/2003US6617332 Cyclic amidinourea derivatives
09/09/2003US6617318 7-substitted tetracyclines are effective against tetracycline-resistant E. coli, S. aureus and E. faecalis strains
09/09/2003US6617317 Boronic ester and acid compositions
09/09/2003US6617315 Therapeutic compounds
09/09/2003US6617306 Therapeutic agent is conjugated to the carrier via a biodegradable disulfide bond.
09/09/2003US6617157 Using inactivating agent of given formula to inactivate any virus contained in donor blood, blood products, or other biological compositions; can also use in vaccines
09/09/2003US6617135 Multiple cytokine protein complexes
09/09/2003US6617101 Lipophilic quenching of viral inactivating agents
09/09/2003US6616931 Containing sugar; phosphate; carboxylate; recombinant human serum albumin or a nonionic surfactant
09/09/2003US6616930 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method
09/09/2003US6616927 Processes for production of immunoglobulin A in milk
09/09/2003US6616925 Combined preparation for the treatment of neoplasic diseases or of infectious diseases
09/09/2003CA2290712C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
09/09/2003CA2263566C Substituted 6,5-hetero-bicyclic derivatives
09/09/2003CA2228655C Preparation of triazoles by organometallic addition to ketones
09/09/2003CA2101648C Polysaccharide-protein conjugates
09/07/2003CA2412065A1 Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus
09/04/2003WO2003073099A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
09/04/2003WO2003073097A2 Methods for isolating ligands e.g. t cell epitopes
09/04/2003WO2003073062A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
09/04/2003WO2003072789A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
09/04/2003WO2003072781A1 Mite galectin
09/04/2003WO2003072766A1 Anti-ccr5 antibody
09/04/2003WO2003072757A2 Nucleotide mimics and their prodrugs
09/04/2003WO2003072725A2 Recombinant negative strand virus rna expression systems and vaccines
09/04/2003WO2003072720A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
1 ... 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 ... 1798